With a combination of fenfluramine or dexfenfluramine (appetite suppressants) and phentermine (an amphetamine), demand for the drug soared and many doctors doled out prescriptions
By targeting both GLP-1 and GIP receptors, tirzepatide can help people manage their diabetes and lose weight in a way that is more comprehensive than medications that only target one receptor
It is currently available in both subcutaneous and oral formulations.4 Furthermore, the impact of high doses of semaglutide on weight loss was explored in adults with overweight or obesity in the STEP programme.5 Recently, the cardiovascular benefit of high doses of semaglutide was also observed in patients with overweight or obesity at high cardiovascular risk but without T2DM.6 Despite the proven cardiovascular benefit of semaglutide, certain safety concerns still linger
Niacinamide 5%: Lm m nm, tn nhang, se kht l chn lng, phc hi hng ro bo v da
This dual action further affects blood sugar control and weight management compared to GLP-1 receptor agonists alone